Literature DB >> 27496300

Identifying Drivers of Episode Cost Variation With Radical Prostatectomy.

Lindsey A Herrel1, John D Syrjamaki1, Susan M Linsell2, David C Miller1, James M Dupree3.   

Abstract

OBJECTIVE: To describe total and component radical prostatectomy (RP) episode costs across a diverse set of hospitals in Michigan, and examine drivers of variation in such payments.
METHODS: We identified Medicare and private payer patients undergoing RP from 2012 to 2014 from the claims-based registry maintained by the Michigan Value Collaborative, a statewide consortium that provides hospitals with price-standardized and risk-adjusted 90-day episode costs for common medical and surgical procedures. We divided hospitals into quartiles based on mean total episode cost for RP. Total episode costs were further classified into 4 payment categories: index hospitalization, professional services, readmissions, and postacute care. Component payments were then compared across high-cost and low-cost hospitals.
RESULTS: We identified 3077 patients undergoing RP in 42 hospitals. Mean 90-day total episode cost was $14,614, ranging from $13,043 to $16,749 across quartiles (28.4% difference, P < .001). Overall variation in total episode cost was divided nearly equally among readmissions (29%), postacute care (29%), and professional payments (26%). We noted significantly higher readmission ($1442 vs $288, P = .03) and postacute care payments at high-cost hospitals ($1686 vs $522, P = .002).
CONCLUSION: Significant variation exists in 90-day total episode costs for RP, suggesting a potential target for bundled payments and other care improvement efforts. Focused efforts on reducing variation in readmissions and postacute care could improve cost-efficiency.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27496300     DOI: 10.1016/j.urology.2016.05.071

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  13 in total

1.  Exploring the Healthcare Value of Percutaneous Coronary Intervention: Appropriateness, Outcomes, and Costs in Michigan Hospitals.

Authors:  Daniel M Alyesh; Milan Seth; David C Miller; James M Dupree; John Syrjamaki; Devraj Sukul; Simon Dixon; Eve A Kerr; Hitinder S Gurm; Brahmajee K Nallamothu
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-06

2.  Variation in Spending around Surgical Episodes of Urinary Stone Disease: Findings from Michigan.

Authors:  Juan San Juan; Hechuan Hou; Khurshid R Ghani; James M Dupree; John M Hollingsworth
Journal:  J Urol       Date:  2017-11-24       Impact factor: 7.450

3.  Who Will be the Costliest Patients? Using Recent Claims to Predict Expensive Surgical Episodes.

Authors:  Karan R Chhabra; Ushapoorna Nuliyalu; Justin B Dimick; Hari Nathan
Journal:  Med Care       Date:  2019-11       Impact factor: 2.983

4.  Drivers of Payment Variation in 90-Day Coronary Artery Bypass Grafting Episodes.

Authors:  Vinay Guduguntla; John D Syrjamaki; Chad Ellimoottil; David C Miller; Richard L Prager; Edward C Norton; Patricia Theurer; Donald S Likosky; James M Dupree
Journal:  JAMA Surg       Date:  2018-01-01       Impact factor: 14.766

5.  Utilization of Pelvic Lymph Node Dissection for Patients With Low-Risk Prostate Cancer Treated With Robot-Assisted Radical Prostatectomy.

Authors:  Parth K Modi; Megan Bock; Sinae Kim; Eric A Singer; Rahul R Parikh
Journal:  Clin Genitourin Cancer       Date:  2017-05-10       Impact factor: 2.872

6.  Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data.

Authors:  Chad Tang; Xiudong Lei; Grace L Smith; Hubert Y Pan; Kenneth Hess; Aileen Chen; Karen E Hoffman; Brian F Chapin; Deborah A Kuban; Mitchell Anscher; Ya-Chen Tina Shih; Steven J Frank; Benjamin D Smith
Journal:  Pract Radiat Oncol       Date:  2020-04-13

7.  Drivers of Variation in 90-Day Episode Payments After Percutaneous Coronary Intervention.

Authors:  Devraj Sukul; Milan Seth; James M Dupree; John D Syrjamaki; Andrew M Ryan; Brahmajee K Nallamothu; Hitinder S Gurm
Journal:  Circ Cardiovasc Interv       Date:  2019-01       Impact factor: 6.546

8.  Use of Routine Home Health Care and Deviations From an Uncomplicated Recovery Pathway After Radical Prostatectomy.

Authors:  Deborah R Kaye; John Syrjamaki; Chad Ellimoottil; Edward W Schervish; M Hugh Solomon; Susan Linsell; James E Montie; David C Miller; James M Dupree
Journal:  Urology       Date:  2017-11-16       Impact factor: 2.649

9.  Outcomes After Percutaneous Coronary Intervention in Patients With a History of Cerebrovascular Disease: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Authors:  Chris Song; Devraj Sukul; Milan Seth; David Wohns; Simon R Dixon; Nicklaus K Slocum; Hitinder S Gurm
Journal:  Circ Cardiovasc Interv       Date:  2018-06       Impact factor: 6.546

10.  Ninety-Day Readmission and Long-Term Mortality in Medicare Patients (≥65 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium).

Authors:  Chris Song; Devraj Sukul; Milan Seth; James M Dupree; Akshay Khandelwal; Simon R Dixon; David Wohns; Thomas LaLonde; Hitinder S Gurm
Journal:  Am J Cardiol       Date:  2017-08-30       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.